Gonzalo J A, Tian J, Delaney T, Corcoran J, Rottman J B, Lora J, Al-garawi A, Kroczek R, Gutierrez-Ramos J C, Coyle A J
Department of Biology, Inflammation Division, Millennium Pharmaceuticals Inc., 45-75 Sidney St., Cambridge, MA 02139, USA.
Nat Immunol. 2001 Jul;2(7):597-604. doi: 10.1038/89739.
We examined the requirement for and cooperation between CD28 and inducible costimulator (ICOS) in effective T helper (TH) cell responses in vivo. We found that both CD28 and ICOS were critical in determining the outcome of an immune response; cytolytic T lymphocyte-associated antigen 4-immunoglobulin (CTLA-4-Ig), ICOS-Ig and/or a neutralizing ICOS monoclonal antibody attenuated T cell expansion, TH2 cytokine production and eosinophilic inflammation. CD28-dependent signaling was essential during priming, whereas ICOS-B7RP-1 regulated TH effector responses, and the up-regulation of chemokine receptors that determine T cell migration. Our data suggests a scenario whereby both molecules regulate the outcome of the immune response but play separate key roles: CD28 primes T cells and ICOS regulates effector responses.
我们研究了体内有效辅助性T(TH)细胞应答过程中CD28与诱导性共刺激分子(ICOS)之间的需求及协同作用。我们发现,CD28和ICOS对于决定免疫应答的结果均至关重要;细胞毒性T淋巴细胞相关抗原4-免疫球蛋白(CTLA-4-Ig)、ICOS-Ig和/或一种中和性ICOS单克隆抗体可减弱T细胞增殖、TH2细胞因子产生及嗜酸性粒细胞炎症。CD28依赖的信号传导在启动阶段至关重要,而ICOS-B7RP-1调节TH效应应答以及决定T细胞迁移的趋化因子受体的上调。我们的数据表明了一种情形,即这两种分子均调节免疫应答的结果,但发挥不同的关键作用:CD28启动T细胞,而ICOS调节效应应答。